The Novio Catalpa team consists of experienced professionals with a track record in the biotech industry. This includes the development of the current golden standard assay for the diagnosis of Rheumatoid Arthritis in collaboration with the Radboud University in the Netherlands.
Experienced team – combining science and business
Strong track record – successful development current leading test
Scientific advisory – supported by leading scientists
Key capabilities in Research & Development, Finance and Business development are represented in the team. Complementary to this the team has the support of an advisory board with members of high reputation in their field.
How we work
Novio Catalpa cooperates with the Department of Biomolecular Chemistry of the Radboud University. The scientists involved have key knowledge for the detection of antibodies related to auto-immune disorders.
Committed cooperation – with the Department of Biomolecular Chemistry of the Radboud University
In depth biochemistry knowledge – working with leading scientists in the field
Execution of high quality research – access to excellent laboratory facilities
Teaming up with leading scientists adds in-depth biochemistry knowledge and unique research skills. Access to sophisticated laboratory facilities to perform our research is another important benefit of this collaboration.
Meet Our Team
We believe that early diagnostics that is accessible for everybody who needs is, when they need it, where they need it, is a top priority in healthcare.
Dr. Martin SaldenCEO / R&D Director
Martin Salden is a Biochemist graduated from the Radboud University of Nijmegen, The Netherlands. He specialized at the laboratory of Haematology in immunology and laboratory diagnostics of auto-immune diseases. For EuroDiagnostica he worked as manager R&D in Arnhem and Nijmegen. He developed the golden standard assay, anti-CCP2, for the serological diagnosis of Rheumatoid Arthritis in collaboration with the department of Biochemistry of the Radboud University (Prof. Walther van Venrooij). Has set up a commercial service laboratory, Wieslab, for auto-immune testing.
Drs. René ReijtenbaghCFO
René Reijtenbagh is a seasoned specialist in private investing. He has a track record in securing funding for startups with a focus on Life sciences and Chemistry. His skills in business development and coaching of startups are an important success factor for this. René holds a masters degree in Economic Geography.
Jyoti Kumari PhDSenior Scientist
Jyoti Kumari is a research scientist in the field of biomedical, with over 10 years of work experience in tissue engineering and biomaterial synthesis. Her PhD work started with the broad application of hydrogels in fibrosis and succeeded in using it for drug screening model. Her aim is to make a meaningful contribution to improve the health of society.
Prof. Ger PruijnAdvisory Board
Prof. Pruijn is Biomolecuar Chemistry Chair at the Radboud University. The research on structure and biological function of biomolecular complexes is important for the detection of antibodies present as a result of auto-immune disorders. Prof. Pruijn’s research group has expert knowledge in this field that is very beneficial for the research and development activities of Novio Catalpa.
“Science knows no country, because knowledge belongs to humanity, and is the torch which illuminates the world. Science is the highest personification of the nation because that nation will remain the first which carries the furthest the works of thought and intelligence.”
Discover The Future
We are a multi-disciplinary research company committed to